Evidence map›Paper›PMID 30083262›Full record

ArticleTheranostics2018

Targeting S1PR1/STAT3 loop abrogates desmoplasia and chemosensitizes pancreatic cancer to gemcitabine.

Manendra Babu Lankadasari, Jayasekharan S Aparna, Sabira Mohammed, Shirley James, Kazunori Aoki, Valsalakumari S Binu, Sindhu Nair, Kuzhuvelil B Harikumar

Open access · goldAbstract read
In one paragraph

Article in Theranostics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 89 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Role of Sphingosine-1-Phosphate Signaling Pathway in Pancreatic Diseases.International journal of molecular sciences · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Inhibitory Effect ofEvidence-based complementary and alternative medicine : eCAM · 2023
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Manendra Babu LankadasariCancer Research Program, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, Kerala State, India 695014.
Jayasekharan S AparnaCancer Research Program, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, Kerala State, India 695014.
Sabira MohammedCancer Research Program, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, Kerala State, India 695014.
Shirley JamesCancer Research Program, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, Kerala State, India 695014.
Kazunori AokiDivision of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.
Valsalakumari S BinuDepartment of Biostatistics, National Institute of Mental and Neurosciences, Bengaluru, India 560029.
Sindhu NairDepartment of Pathology, Regional Cancer Centre, Thiruvananthapuram, India 695025.
Kuzhuvelil B HarikumarCancer Research Program, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, Kerala State, India 695014.
Rajiv Gandhi Centre for Biotechnology · INManipal Academy of Higher Education · INNational Institute of Mental Health and Neurosciences · INRegional Cancer Center, Thiruvananthapuram · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAntimetabolites, AntineoplasticApoptosisCell CycleCell ProliferationDeoxycytidineDisease Models, AnimalDrug Therapy, CombinationFingolimod HydrochlorideGemcitabineHumansMiceModels, BiologicalPancreatic NeoplasmsReceptors, LysosphingolipidSphingosine-1-Phosphate ReceptorsAntimetabolites, AntineoplasticDeoxycytidineFingolimod HydrochlorideGemcitabineReceptors, LysosphingolipidS1PR1 protein, humanS1pr1 protein, mouseSphingosine-1-Phosphate ReceptorsSTAT3 protein, humanStat3 protein, mouseSTAT3 Transcription FactorFTY720gemcitabinemetastasispancreatic cancerPP2AS1P receptor 1STAT3

Identifiers

PMID30083262
PMCPMC6071521
OpenAlexW2809387065

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.